Krish Pharma Speciality Private Limited agreed to acquire 24.7% stake in Shreyas Intermediates Limited from Invent Assets Securitization and Reconstruction Private Limited for INR 175 million

Krish Pharma Speciality Private Limited agreed to acquire 24.7% stake in Shreyas Intermediates Limited from Invent Assets Securitization and Reconstruction Private Limited for INR 175 million on March 17, 2022. In a related transaction, Krish Pharma Speciality Private Limited made an offer to acquire 8.64% stake in Shreyas Intermediates Limited (BSE:526335) for INR 61.2 million on March 17, 2022. The transaction is subject to regulatory approval.

Fedex Securities Limited acted as financial advisor to Shreyas Intermediates